Durability of Pulmonary Vein Isolation With the Heliostar Radiofrequency Balloon—The Prospective RABAAF Study With Protocol‐Mandated Repeat Electrophysiology Studies
Authors:
- Samuel K. SørensenSSSamuel K. Sørensen
- Lise D. Riis‐VestergaardLRLise D. Riis‐Vestergaard
- Jacob TønnesenJTJacob Tønnesen
- Arne JohannessenAJArne Johannessen
- René WorckRWRené Worck
- Kristian EskesenKEKristian Eskesen
- German BertoloGBGerman Bertolo
- Maria MayorgaMMMaria Mayorga
- Martin H. RuwaldMRMartin H. Ruwald
- Morten L. HansenMHMorten L. Hansen
- Jim HansenJHJim Hansen
- 15 July 2025
- journal article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
Abstract
Introduction: Pulmonary vein isolation (PVI) is the cornerstone in atrial fibrillation (AF) ablation but achieving durable PVI remains a challenge. The radiofrequency balloon (RFB) is a “single‐shot” ablation catheter for PVI that offers selective energy titration from 10 surface electrodes and 3D mapping system integration. The durability of RFB PVI has not been investigated.Methods: The objective of this study was to evaluate the durability of RFB PVI by protocol‐mandated remaps in patients with paroxysmal or persistent AF referred for AF ablation at a high‐volume center. RFB procedures were performed under conscious sedation, PVI assessed by high‐density mapping, bidirectional block confirmed after a waiting period of ≥ 20 min, and dormant conduction assessed by adenosine injections. After 4–6 months patients underwent a remap study for assessment of PVI durability by high‐density mapping and assessment of bidirectional block.Results: Forty‐five patients were enrolled, 43 completed the RFB PVI, and 35/43 (81%) completed the remap study: 26% female, 43% persistent AF, median age 65 (interquartile range: 61–69) years, median CHA2DS2‐VASc score 1 (0–2), and median left atrial volume 31 (25–42) mL/m2. Acute PVI was achieved in 99% of pulmonary veins (PVs) but focal radiofrequency touch‐up lesions were required in 31% of patients. After 5.4 (4.9–6.1) months, 71% of PVs were durably isolated, and 29% of patients had all PVs durably isolated; 86% of patients were free from documented atrial tachyarrhythmias.Conclusion: The durability of RFB PVI achieved under conscious sedation was relatively low. However, medium‐term freedom from clinical recurrent arrhythmia was favorable.Trial Registration: URL: https://www.clinicaltrials.gov. Unique Identifier: NCT06296888.Keywords
Funding Information
- Gentofte Hospital
This publication has 19 references indexed in Scilit:
- Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial FibrillationNew England Journal of Medicine, 2025
- Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial FibrillationNew England Journal of Medicine, 2023
- Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF)EP Europace, 2022
- Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillationEP Europace, 2021
- Cryoballoon Ablation as Initial Therapy for Atrial FibrillationNew England Journal of Medicine, 2021
- Safety, effectiveness, and quality of life following pulmonary vein isolation with a multi-electrode radiofrequency balloon catheter in paroxysmal atrial fibrillation: 1-year outcomes from SHINEEP Europace, 2021
- 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillationEP Europace, 2017
- Temperature-Controlled Radiofrequency Ablation for Pulmonary Vein Isolation in Patients With Atrial FibrillationJACC, 2017
- Pulmonary vein reconnection following catheter ablation of atrial fibrillation using the second-generation cryoballoon versus open-irrigated radiofrequency: results of a multicenter analysisJournal of Interventional Cardiac Electrophysiology, 2016
- Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial FibrillationNew England Journal of Medicine, 2016